Is moderate hypofractionation accepted as a new standard of care in north america for prostate cancer patients treated with external beam radiotherapy? Survey of genitourinary expert radiation oncologists.

Int Braz J Urol · 2019 · PMC6541148 · PMID 30676300

Europe PMC DOI

hedged sentence

0.0890

closest p · 1.8× alpha

0.0890

boldest claim

The sentences

approached significancep = 0.089so close (0.05 < p ≤ 0.1)

Only the choice of brachytherapy as a preferred treatment option for patients with low - risk prostate cancer approached significance for recommendation of hypofractionation (p = 0.089) ( Table-2 ).

also in 8,237 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.